{"altmetric_id":6065841,"counts":{"readers":{"mendeley":51,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["bjemec"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa6113cf058f610006ef4","authors":["Morton DL","Donald L. Morton"],"doi":"10.1007\/s10585-012-9503-3","endpage":"706","first_seen_on":"2016-03-04T19:22:23+00:00","funders":["nci"],"issns":["0262-0898","1573-7276"],"issue":"7","journal":"Clinical and Experimental Metastasis","last_mentioned_on":1500152419,"links":["https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3463679\/"],"pmid":"22729520","pubdate":"2012-10-14T23:00:00+00:00","publisher":"NIH Public Access","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"699","subjects":["neoplasms"],"title":"Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma.","type":"article","volume":"29","mendeley_url":"http:\/\/www.mendeley.com\/research\/overview-update-phase-iii-multicenter-selective-lymphadenectomy-trials-mslti-msltii-melanoma"},"altmetric_score":{"score":0.5,"score_history":{"1y":0.5,"6m":0.5,"3m":0.5,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":8213597,"mean":6.9554318223036,"rank":6236914,"this_scored_higher_than_pct":13,"this_scored_higher_than":1105784,"rank_type":"exact","sample_size":8213597,"percentile":13},"similar_age_3m":{"total_number_of_other_articles":287436,"mean":11.024855052446,"rank":203429,"this_scored_higher_than_pct":14,"this_scored_higher_than":41964,"rank_type":"exact","sample_size":287436,"percentile":14},"this_journal":{"total_number_of_other_articles":242,"mean":2.1483070539419,"rank":132,"this_scored_higher_than_pct":28,"this_scored_higher_than":68,"rank_type":"exact","sample_size":242,"percentile":28},"similar_age_this_journal_3m":{"total_number_of_other_articles":7,"mean":1.6,"rank":4,"this_scored_higher_than_pct":14,"this_scored_higher_than":1,"rank_type":"exact","sample_size":7,"percentile":14}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":2,"Student  > Doctoral Student":6,"Researcher":6,"Student  > Ph. D. Student":5,"Student  > Postgraduate":6,"Student  > Master":10,"Other":7,"Student  > Bachelor":5,"Professor":3},"by_discipline":{"Medicine and Dentistry":41,"Psychology":2,"Agricultural and Biological Sciences":3,"Unspecified":3,"Pharmacology, Toxicology and Pharmaceutical Science":1,"Veterinary Science and Veterinary Medicine":1}}},"geo":{"twitter":{"GB":1},"mendeley":{"US":1,"IT":1,"CL":1,"ES":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/bjemec\/statuses\/886329602083348480","license":"gnip","citation_ids":[6065841],"posted_on":"2017-07-15T21:00:19+00:00","author":{"name":"Barbara Jemec","url":"http:\/\/www.barbarajemec.com","image":"https:\/\/pbs.twimg.com\/profile_images\/565625648169750528\/ceyL7Flh_normal.jpeg","description":"I am a #plasticsurgeon with specialist interest in #hand and #reconstructive surgery. Founding Chairman of BFIRST (@BFIRSTraining). BAPRAS council #charity","id_on_source":"bjemec","tweeter_id":"359404694","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":13580},"tweet_id":"886329602083348480"}]}}